{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:29:10Z","timestamp":1790767750075,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005205","name":"J&amp;J Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AI148102"],"award-info":[{"award-number":["P01AI148102"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ard.2026.06.007","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:31:26Z","timestamp":1783135886000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["PD-1 signalling restrains pathogenic T peripheral helper and effector CD4\u207a T cell functions in rheumatoid arthritis"],"prefix":"10.1016","author":[{"given":"Kazuhiko","family":"Higashioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Sowerby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryne E.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Pena-Nunez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina E.","family":"Bracero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret H.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Coblyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena M.","family":"Massarotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Yang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak A.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ard.2026.06.007_bib0001","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V","article-title":"The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis","volume":"43","author":"Tak","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.ard.2026.06.007_bib0002","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrrheum.2014.115","article-title":"Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis","volume":"10","author":"Catrina","year":"2014","journal-title":"Nat Rev Rheumatol."},{"issue":"1","key":"10.1016\/j.ard.2026.06.007_bib0003","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/imr.12827","article-title":"Advances in genetics toward identifying pathogenic cell states of rheumatoid arthritis","volume":"294","author":"Amariuta","year":"2020","journal-title":"Immunol Rev."},{"issue":"7639","key":"10.1016\/j.ard.2026.06.007_bib0004","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature."},{"issue":"11","key":"10.1016\/j.ard.2026.06.007_bib0005","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1002\/art.40218","article-title":"Synovial immunophenotype and anti-citrullinated peptide antibodies in rheumatoid arthritis patients: relationship to treatment response and radiologic prognosis","volume":"69","author":"Orr","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.ard.2026.06.007_bib0006","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/annrheumdis-2018-214539","article-title":"Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients","volume":"78","author":"Humby","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ard.2026.06.007_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102283","article-title":"Immune checkpoint receptors in autoimmunity","volume":"80","author":"Burke","year":"2023","journal-title":"Curr Opin Immunol."},{"issue":"4","key":"10.1016\/j.ard.2026.06.007_bib0008","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.ard.2026.06.007_bib0009","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/art.41587","article-title":"Expert perspective: immune checkpoint inhibitors and rheumatologic complications","volume":"73","author":"Cappelli","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"7","key":"10.1016\/j.ard.2026.06.007_bib0010","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","article-title":"Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry","volume":"20","author":"Zhang","year":"2019","journal-title":"Nat Immunol."},{"issue":"5","key":"10.1016\/j.ard.2026.06.007_bib0011","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T Follicular helper cell biology: a decade of discovery and diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity."},{"issue":"20","key":"10.1016\/j.ard.2026.06.007_bib0012","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1056\/NEJMoa2209856","article-title":"A phase 2 trial of peresolimab for adults with rheumatoid arthritis","volume":"388","author":"Tuttle","year":"2023","journal-title":"N Engl J Med."},{"issue":"suppl 9","key":"10.1016\/j.ard.2026.06.007_bib0013","article-title":"Rosnilimab, a selective and potent depleter of pathogenic T cells, demonstrates efficacy, safety, and translational proof of mechanism in a rheumatoid arthritis phase 2B trial","volume":"77","author":"Graf","year":"2025","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ard.2026.06.007_bib0014","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X251385857","article-title":"Safety, tolerability, and efficacy of the PD-1 agonist antibody JNJ-67484703 in adults with active rheumatoid arthritis: results of a multicenter, double-blind, placebo-controlled, randomized, multiple-dose phase Ib study","volume":"17","author":"Ling","year":"2025","journal-title":"Ther Adv Musculoskelet Dis."},{"issue":"1","key":"10.1016\/j.ard.2026.06.007_bib0015","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s42003-023-04874-3","article-title":"Anti-human-TIGIT agonistic antibody ameliorates autoimmune diseases by inhibiting Tfh and Tph cells and enhancing Treg cells","volume":"6","author":"Kojima","year":"2023","journal-title":"Commun Biol."},{"issue":"1","key":"10.1016\/j.ard.2026.06.007_bib0016","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1189\/jlb.1107753","article-title":"BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice","volume":"86","author":"Truong","year":"2009","journal-title":"J Leukoc Biol."},{"issue":"2","key":"10.1016\/j.ard.2026.06.007_bib0017","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41584-025-01296-9","article-title":"PD-1, BTLA and TIGIT as therapeutic targets for rheumatic disease","volume":"22","author":"Kuchroo","year":"2026","journal-title":"Nat Rev Rheumatol"},{"issue":"27","key":"10.1016\/j.ard.2026.06.007_bib0018","doi-asserted-by":"crossref","first-page":"E2480","DOI":"10.1073\/pnas.1305394110","article-title":"Strength of PD-1 signaling differentially affects T-cell effector functions","volume":"110","author":"Wei","year":"2013","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"7987","key":"10.1016\/j.ard.2026.06.007_bib0019","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-023-06708-y","article-title":"Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes","volume":"623","author":"Zhang","year":"2023","journal-title":"Nature."},{"issue":"6440","key":"10.1016\/j.ard.2026.06.007_bib0020","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1126\/science.aav7062","article-title":"Restriction of PD-1 function by cis-PD-L1\/CD80 interactions is required for optimal T cell responses","volume":"364","author":"Sugiura","year":"2019","journal-title":"Science."},{"issue":"2","key":"10.1016\/j.ard.2026.06.007_bib0021","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.immuni.2024.01.006","article-title":"An atlas of cells in the human tonsil","volume":"57","author":"Massoni-Badosa","year":"2024","journal-title":"Immunity."},{"issue":"5","key":"10.1016\/j.ard.2026.06.007_bib0022","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2353\/ajpath.2006.050999","article-title":"Cadherin-11 induces rheumatoid arthritis fibroblast-like synoviocytes to form lining layers in vitro","volume":"168","author":"Kiener","year":"2006","journal-title":"Am J Pathol."},{"issue":"7811","key":"10.1016\/j.ard.2026.06.007_bib0023","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-020-2222-z","article-title":"Notch signalling drives synovial fibroblast identity and arthritis pathology","volume":"582","author":"Wei","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.ard.2026.06.007_bib0024","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-immunol-092419-031130","article-title":"Age-Associated B Cells","volume":"38","author":"Cancro","year":"2020","journal-title":"Annu Rev Immunol"},{"issue":"34","key":"10.1016\/j.ard.2026.06.007_bib0025","doi-asserted-by":"crossref","first-page":"E3216","DOI":"10.1073\/pnas.1312348110","article-title":"T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance","volume":"110","author":"Rubtsova","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.ard.2026.06.007_bib0026","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.4049\/jimmunol.1600522","article-title":"Cutting edge: IL-4, IL-21, and IFN-\u03b3 interact to govern T-bet and CD11c expression in TLR-activated B cells","volume":"197","author":"Naradikian","year":"2016","journal-title":"J Immunol."},{"issue":"21","key":"10.1016\/j.ard.2026.06.007_bib0027","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139032","article-title":"Pathogenic, glycolytic PD-1+ B cells accumulate in the hypoxic RA joint","volume":"5","author":"Floudas","year":"2020","journal-title":"JCI Insight."},{"issue":"7077","key":"10.1016\/j.ard.2026.06.007_bib0028","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature."},{"issue":"6","key":"10.1016\/j.ard.2026.06.007_bib0029","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ni.1877","article-title":"PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells","volume":"11","author":"Good-Jacobson","year":"2010","journal-title":"Nat Immunol."},{"issue":"1","key":"10.1016\/j.ard.2026.06.007_bib0030","doi-asserted-by":"crossref","DOI":"10.1172\/JCI135468","article-title":"Tissue-resident PSGL1loCD4+ T cells promote B cell differentiation and chronic graft-versus-host disease-associated autoimmunity","volume":"131","author":"Kong","year":"2021","journal-title":"J Clin Invest."},{"issue":"2","key":"10.1016\/j.ard.2026.06.007_bib0031","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.immuni.2018.06.012","article-title":"PD-1 controls follicular T helper cell positioning and function","volume":"49","author":"Shi","year":"2018","journal-title":"Immunity"},{"issue":"13","key":"10.1016\/j.ard.2026.06.007_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107827","article-title":"The PD-1 pathway regulates development and function of memory CD8+ T cells following respiratory viral infection","volume":"31","author":"Pauken","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ard.2026.06.007_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1161067","article-title":"The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions","volume":"14","author":"Carlini","year":"2023","journal-title":"Front Immunol."},{"issue":"31","key":"10.1016\/j.ard.2026.06.007_bib0034","doi-asserted-by":"crossref","first-page":"eabb0806","DOI":"10.1126\/sciadv.abb0806","article-title":"IL-10-producing Tfh cells accumulate with age and link inflammation with age-related immune suppression","volume":"6","author":"Almanan","year":"2020","journal-title":"Sci Adv."},{"issue":"1","key":"10.1016\/j.ard.2026.06.007_bib0035","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1038\/s41467-018-07492-4","article-title":"Single-cell RNA sequencing unveils an IL-10-producing helper subset that sustains humoral immunity during persistent infection","volume":"9","author":"Xin","year":"2018","journal-title":"Nat Commun."},{"issue":"16","key":"10.1016\/j.ard.2026.06.007_bib0036","doi-asserted-by":"crossref","first-page":"eaan4767","DOI":"10.1126\/sciimmunol.aan4767","article-title":"Interleukin-10 from CD4+ follicular regulatory T cells promotes the germinal center response","volume":"2","author":"Laidlaw","year":"2017","journal-title":"Sci Immunol."},{"issue":"2","key":"10.1016\/j.ard.2026.06.007_bib0037","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/rheumatology\/kew393","article-title":"Targeting non-canonical nuclear factor-\u03baB signalling attenuates neovascularization in a novel 3D model of rheumatoid arthritis synovial angiogenesis","volume":"56","author":"Maracle","year":"2017","journal-title":"Rheumatology (Oxford)."},{"issue":"6","key":"10.1016\/j.ard.2026.06.007_bib0038","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/acf976","article-title":"Human vascularised synovium-on-a-chip: a mechanically stimulated, microfluidic model to investigate synovial inflammation and monocyte recruitment","volume":"18","author":"Thompson","year":"2023","journal-title":"Biomed Mater."},{"issue":"9","key":"10.1016\/j.ard.2026.06.007_bib0039","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.celrep.2019.07.091","article-title":"Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes","volume":"28","author":"Lewis","year":"2019","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.ard.2026.06.007_bib0040","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/art.42749","article-title":"Programmed death ligand 1-expressing macrophages and their protective role in the joint during arthritis","volume":"76","author":"Wood","year":"2024","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ard.2026.06.007_bib0041","article-title":"Programmed death ligand 2 \u2013 a link between inflammation and bone loss in rheumatoid arthritis","volume":"3","author":"Greisen","year":"2019","journal-title":"J Transl Autoimmun"},{"issue":"5","key":"10.1016\/j.ard.2026.06.007_bib0042","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1084\/jem.20130790","article-title":"RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance","volume":"211","author":"Xiao","year":"2014","journal-title":"J Exp Med."},{"key":"10.1016\/j.ard.2026.06.007_bib0043","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"issue":"17","key":"10.1016\/j.ard.2026.06.007_bib0044","doi-asserted-by":"crossref","first-page":"E4041","DOI":"10.1073\/pnas.1720948115","article-title":"Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment","volume":"115","author":"Peranzoni","year":"2018","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"9","key":"10.1016\/j.ard.2026.06.007_bib0045","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1073\/pnas.0931259100","article-title":"PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells","volume":"100","author":"Loke","year":"2003","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"10","key":"10.1016\/j.ard.2026.06.007_bib0046","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1002\/eji.200324228","article-title":"Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses","volume":"33","author":"Liang","year":"2003","journal-title":"Eur J Immunol."},{"issue":"3","key":"10.1016\/j.ard.2026.06.007_bib0047","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/art.41958","article-title":"Effect of JAK inhibition on the induction of proinflammatory HLA-DR+CD90+ rheumatoid arthritis synovial fibroblasts by interferon-\u03b3","volume":"74","author":"Zhao","year":"2022","journal-title":"Arthritis Rheumatol."},{"issue":"22","key":"10.1016\/j.ard.2026.06.007_bib0048","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.193054","article-title":"Rheumatoid arthritis synovial fibroblasts modulate T cell activation","volume":"10","author":"Romoff","year":"2025","journal-title":"JCI Insight."},{"issue":"1","key":"10.1016\/j.ard.2026.06.007_bib0049","doi-asserted-by":"crossref","first-page":"uxaf035","DOI":"10.1093\/cei\/uxaf035","article-title":"Engaging PD-1 rescuesregulatory T cell function and inhibits inflammatory T cells in rheumatoid arthritis","volume":"219","author":"Chowdhury","year":"2025","journal-title":"Clin Exp Immunol."},{"issue":"7","key":"10.1016\/j.ard.2026.06.007_bib0050","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.3390\/ijms26072998","article-title":"PD-L1+ regulatory B cells from rheumatoid arthritis patients have impaired function in suppressing IFN-\u04af and IL-21 production","volume":"26","author":"Talib","year":"2025","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.ard.2026.06.007_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1403680","article-title":"Insufficient PD-1 expression during active autoimmune responses: a deep single-cell proteomics analysis in inflammatory arthritis","volume":"15","author":"Vetsika","year":"2024","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.ard.2026.06.007_bib0052","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-1 and inhibits T cell activation","volume":"2","author":"Latchman","year":"2001","journal-title":"Nat Immunol."}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726003559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726003559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T23:14:39Z","timestamp":1785971679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496726003559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":52,"alternative-id":["S0003496726003559"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2026.06.007","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-1 signalling restrains pathogenic T peripheral helper and effector CD4\u207a T cell functions in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2026.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}